NDC 81033-124-06 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-124
- Requested NDC
- 81033-124-06
- Package NDCs from labels
- 81033-124-06, 81033-124-44
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2025-09-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Kesin Pharma Corporation | Kesin Pharma Corporation | 2025-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-124-06 | Gabapentin | 6 mL in 1 CUP, UNIT-DOSE | SOLUTION | 6 | 1 | |
| 81033-124-44 | Gabapentin | 40 in 1 CARTON | SOLUTION | 40 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-124-06 | ML - Milliliter | 81033-124 | dac763c1-c481-43a1-86d4-7d259050a2c0 | 1 | 2025-10-14 |
| 81033-124-44 | ML - Milliliter | 81033-124 | 55a1fe8c-d9ba-4f1c-9663-d8638e8de22d | 1 | 2025-10-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Strides Pharma Science Limited | 43b67ae3-ac6f-48f5-8788-9ead08376864 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9d401e54-d4f5-43ba-b898-dd08fc3c7bfa | 2026-07-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gralise | GABAPENTIN | Almatica Pharma LLC | 466273b1-c9fc-3930-c94b-aa11394d5140 | 2026-06-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | 14d61caa-17ce-4fa2-90fb-1470f3864be8 | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 2bc65375-77b8-1e50-e063-6294a90acf8f | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | PDC6A3C0OX |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | PDC6A3C0OX |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.